Live Breaking News & Updates on Tace

Stay informed with the latest breaking news from Tace on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Tace and stay connected to the pulse of your community

HCC Trials: Insights from the LAUNCH, EMERALD-1, and LEAP-012 Trials

Medical experts discuss the LAUNCH study, EMERALD-1, and LEAP-012 trials, providing updates on the progress and findings that influence the treatment paradigm for hepatocellular carcinoma.

Tyrosine-kinase-inhibitors , Unresectable-hepatocellular-carcinoma , Hepatocellular-carcinoma , Hcc , Tace , Transarterial-chemoembolization , Lenvatinib , Launch-study , Emerald-1-study , Durvalumab , Bevacizumab

Utilizing Interventional Radiology and Liver-directed Therapies

Mechanism of action for liver-directed therapies in HCC are illustrated by Anne Covey, MD, an interventional radiologist.

Evolving-treatments , Hepatocellular-carcinoma , Interventional-radiology , Hcc , Hcc-treatment , Liver-cancer , Liver-cancer-therapy , Ir , Interventional-radiologist , Liver-directed-therapy , Tace

Durvalumab and Bevacizumab Plus TACE Improves PFS in Embolization-Eligible, Unresectable HCC

PFS was significantly improved with durvalumab plus bevacizumab and TACE vs TACE alone in patients with unresectable HCC eligible for embolization.

Italy , Japan , Riccardo-lencioni , Department-of-surgery , Critical-area-pathology , Druvalumab-and-bevacizumab-plus-tace , Tace , Hcc , Hepatocellular-carcinoma , Gastrointestinal-cancer , Gi-cancer , Asco-gi

Dr Bruno Sangro Discusses Results for EMERALD-1 in Unresectable Hepatocellular Carcinoma

The study’s senior author discusses how the combined mechanisms of action produced benefit in progression-free survival.

United-states , Spain , American , Spanish , Durvalumab-imfinzi , Bruno-sangro , American-cancer-society-facts , Spanish-network-for-biomedical-research-on-hepatic , Astrazeneca , American-society , American-journal , Managed-care

The 11th Hour With Stephanie Ruhle

rabbit hole goes deep enough potential criminal prosecution but we are a long way off from that i do think that the question o investigation is paramount, in as much as, you cannot eve talk about integrity if you're not willing to look into wha this does, or what this says or what is here. now once you learn what is here, the question then is, what d we do about it and i understand that that creates a whole, another rabbi hole of different problems tha you have to go down an consider but to not do the investigatio itself, wreaks of impropriety, and i think it's something people have to be really concerned about. >> people deserve to know th truth. new topic, same court. last week the supreme cour basically said, let's put on hold making a ruling about access to this abortion pill that expires on wednesday, wha do you think's gonna happen? this is the same cou tha >>is, i do thinkhat we are gog to see the c in on this bu because not doing s iso create a ton o nfusiohe decisions th are tace, and h that camout of twhicis started hole thian authority that has and so, ify let nd the questin becomes, wha hey open door to ope s, other medicalf othe practi and doctors able to don't lik the s rulithis, don't like the fact th toenge it.nd so now i think that that going tbe thn at the sup court in terms of actually looking a case, and going forward with it, and not counting on the issue. >> charles coleman, you always make us smarter, thank you for being here coming up, almost half the country's independent. so why are our lawmakers s hyper partisan when the 11th hour continues away things. fit together with away things. ♪ ♪

Wha , Way , Question , Talk , Prosecution , Rabbi-hole , Whole , Question-o-investigation-is-paramount , Integrity , Something , People , Suprem

Closing Thoughts on Advanced HCC and Highlights from ASCO GI 2023

Closing out this discussion, experts share their final thoughts on advanced HCC treatments and key data presented at the 2023 ASCO Gastrointestinal Cancers Symposium.

Transforming-outcomes , Hepatocellular-carcinoma , Expert-insights , Applying-evidence , Hcc , Intermediate-stage , Systemic-therapy , Bclc-stage-b , Patient-selection , Locoregional , Tace

Beasley Broadcast : Stacie Waldrop Named Digital Sales Manager at Beasley Media Group Tampa

Beasley Media Group announces Stace Waldrop has been named as the new Digital Sales Manager at Beasley Media Group's Tampa-based radio cluster. She will officially begin her new... | April 4, 2023

Beasley-tampa , Stace-waldrop , Gannett-united-states-today-network , Beasley-media-group , Digital-sales-manager , Regional-digital-sales-manager , Summit-media , United-states-today-network , Vice-president , Market-manager-ron , Beasley-broadcast-group , Nc-stock-exchange

Systemic Immunotherapies for Advanced HCC in Second Line and Beyond

In the context of frontline treatment strategies in advanced HCC, expert oncologists review clinical research in systemic immunotherapy approaches.

Transforming-outcomes , Hepatocellular-carcinoma , Expert-insights , Applying-evidence , Second-line , Hcc , Intermediate-stage , Systemic-therapy , Bclc-stage-b , Patient-selection , Locoregional

Anti-Angiogenic Systemic Therapies for Advanced HCC in Second Line and Beyond

Expert panelists highlight anti-angiogenic systemic therapies under investigation for advanced HCC in second line and beyond.

Transforming-outcomes , Hepatocellular-carcinoma , Expert-insights , Applying-evidence , Angiogenic-systemic-therapies , Second-line , Hcc , Intermediate-stage , Systemic-therapy , Bclc-stage-b , Patient-selection

The Ingraham Angle

in new hampshire, democrats ner thought they'd have to defend seats there. meanwhile, governors abbott and texas to santurce in florida and camp in georgia aree al up double digits over their democrat rivals. >> and why this all happening? because the truth is getting tord for to hard for the press f avoid. democrat policies havet left americans poorer, our country weaker, and with the addedof bonus of taking us to the brinkb of an all out war with russia and there's going to be a huge political price to be paid for this. yen t rather than trying to tace to the middle democrats, they just keep digging themselves further into a holed and now populist republican candidates who are bold and who are brave are. about to bury them.g them now, they keptse tellingie themselves, lie after lie. the democrats first that inflation was transitory. i see important transitory influences work, and i don't

Democrats , Digits , Camp , New-hampshire , Seats , Happening , Santurce , Abbott , Rivals , Georgia-aree-al , Democrats-ner , Texas